FiercePharma

First Subjects Enrolled in Phase IIa Clinical Trial of EPODURE Biopumps to Treat Anemia in Patients with End-Stage Renal Disease on Dialysis

First Subjects Enrolled in Phase IIa Clinical Trial of EPODURE Biopumps to Treat Anemia in Patients with End-Stage Renal Disease on Dialysis MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Jul. 17, ...
Nature

Short-Term Effect of Erythropoietin on Brain Lesions and Aquaporin-4 Expression in a Hypoxic-Ischemic Neonatal Rat Model Assessed by Magnetic Resonance Diffusion Weighted ...

Erythropoietin (Epo) is an endogenous cytokine that regulates hematopoiesis and is widely used to treat anemia. In addition, it has recently increased interest in the neurosciences since the new ...
Mena FN

Erythropoietin Drugs Market Size To Reach USD 18.45 Billion By 2035 Due To The Increasing Prevalence Of Chronic Kidney Disease And Cancer-Related Anemia Globally SNS Insider

(MENAFN- GlobeNewsWire - Nasdaq) U.S. Erythropoietin Drugs Market size was USD 4.02 Billion in 2025 and is expected to reach USD 6.18 Billion by 2035 owing to the strong dialysis infrastructure and ...